Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:13 PM
Ignite Modification Date:
2025-12-24 @ 12:13 PM
NCT ID:
NCT02066961
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of prostate adenocarcinoma
* Will receive a new intervention at the time of study entry, for the treatment of:
* Biochemical failure after initial curative-intent surgery (radical prostatectomy) or radiotherapy (external-beam radiation therapy, brachytherapy, or both) and a PSA doubling time of one year or less or a confirmed PSA of ≥ 50 ng/mL (2 consecutive values) within 6 months prior to study entry; or
* Castration-resistant prostate cancer; or
* Metastatic prostate cancer at initial diagnosis of prostate cancer
Exclusion Criteria:
* Prior treatment of metastatic castration-resistant prostate cancer with systemic chemotherapy
* Life expectancy of \<1 year due to comorbidities
Healthy Volunteers:
False
Sex:
MALE
Study:
NCT02066961
Study Brief:
Protocol Section:
NCT02066961